SPRY R&D Expense Growth
Ars Pharmaceuticals Inc · R&D Expense Growth
SPRY R&D Expense Growth
Latest reported-32.68%period ending
SPRY FY R&D Growth (YoY) (0.00% → -32.68%)
Latest values, visible window
High-resolution chart · PNG
SPRY r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -32.6813% | |
| -3.385% | |
| 10.2852% | |
| -9.3573% | |
| 44.0867% | |
| -34.5734% | |
| 45.2648% | |
| 0% |